| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | GRPH | Common Stock | Options Exercise | $27.4K | +91.4K | +47.97% | $0.30* | 282K | Jan 15, 2021 | Direct | F1, F2 |
| transaction | GRPH | Common Stock | Options Exercise | $20.7K | +3.38K | +1.2% | $6.11 | 285K | Apr 18, 2021 | Direct | F1, F2 |
| transaction | GRPH | Common Stock | Conversion of derivative security | +8.13K | +2.85% | 293K | Jun 29, 2021 | Direct | F3 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | GRPH | Stock Option (right to buy) | Award | $0 | +91.4K | $0.00 | 91.4K | Jan 13, 2021 | Common Stock | 91.4K | $0.30 | Direct | F1, F2, F4 | |
| transaction | GRPH | Stock Option (right to buy) | Options Exercise | $0 | -91.4K | -100% | $0.00* | 0 | Jan 15, 2021 | Common Stock | 91.4K | $0.30 | Direct | F1, F2, F4 |
| transaction | GRPH | Series B Preferred Stock | Award | $100K | +19.8K | $5.06 | 19.8K | Mar 11, 2021 | Common Stock | 8.13K | Direct | F1, F3 | ||
| transaction | GRPH | Stock Option (right to buy) | Award | $0 | +162K | $0.00 | 162K | Mar 17, 2021 | Common Stock | 162K | $6.11 | Direct | F1, F2, F5 | |
| transaction | GRPH | Stock Option (right to buy) | Award | $0 | +69.6K | $0.00 | 69.6K | Mar 17, 2021 | Common Stock | 69.6K | $6.11 | Direct | F2, F6 | |
| transaction | GRPH | Stock Option (right to buy) | Options Exercise | $0 | -3.38K | -2.08% | $0.00 | 159K | Apr 18, 2021 | Common Stock | 3.38K | $6.11 | Direct | F1, F2, F5 |
| transaction | GRPH | Series B Preferred Stock | Conversion of derivative security | $0 | -19.8K | -100% | $0.00* | 0 | Jun 29, 2021 | Common Stock | 8.13K | Direct | F3 |
| Id | Content |
|---|---|
| F1 | This transaction occurred prior to the Issuer's initial public offering ("IPO") and is being reported on Form 4 solely for purposes of compliance with Rule 16a-2(a) under the Securities Exchange Act of 1934, as amended. The securities covered by such transaction were previously included on the Reporting Person's Form 3. |
| F2 | On June 21, 2021, the Issuer completed a one-for-2.432 reverse stock split of the Issuer's Common Stock ("Reverse Stock Split"). This amount has been adjusted to give effect to this Reverse Stock Split. |
| F3 | These shares of Series B Preferred Stock were convertible at any time at the holder's election and automatically converted on a 2.432-for-one basis into shares of the Issuer's common stock immediately upon the closing of the IPO without payment of additional consideration. The Series B Preferred Stock had no expiration date. |
| F4 | 25% of the shares subject to such option vest and become exercisable when the Reporting Person completes twelve months of continuous service after October 5, 2020, and the remainder of the shares vest and become exercisable in substantially equal monthly installments for a period of 36 months thereafter, subject to the Reporting Person's continuous service to the Issuer on each such date. The option provides for an early exercise provision of unvested shares, subject to the Issuer's right to repurchase. |
| F5 | 1/48th of the shares subject to such option vest and become exercisable in substantially equal monthly installments on each monthly anniversary of March 17, 2021, subject to the Reporting Person's continuous service to the Issuer on each such date. |
| F6 | The option was granted subject to the achievement by the Company of performance vesting criteria. On June 29, 2021 the performance vesting criteria was met such that the option became reportable. 1/48th of the shares subject to such option vest and become exercisable in substantially equal monthly installments on each monthly anniversary of March 17, 2021, subject to the Reporting Person's continuous service to the Issuer on each such date. |